Dr. Martens plc (LON:DOCS – Get Free Report) shares were down 9.6% on Friday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. Approximately 4,733,644 shares were traded during mid-day trading, an increase of 115% from the average daily volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.
Analyst Ratings Changes
Separately, Peel Hunt restated a “buy” rating on shares of Dr. Martens in a report on Thursday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Dr. Martens has an average rating of “Hold” and a consensus target price of GBX 6,000.
Check Out Our Latest Analysis on Dr. Martens
Dr. Martens Trading Down 1.8%
Dr. Martens (LON:DOCS – Get Free Report) last released its earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Sell-side analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Insider Transactions at Dr. Martens
In other news, insider Giles Wilson sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, September 1st. The shares were sold at an average price of GBX 91, for a total transaction of £27,300. Also, insider Ije Nwokori sold 298,675 shares of Dr. Martens stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total transaction of £268,807.50. In the last quarter, insiders have purchased 136,960 shares of company stock valued at $12,460,163 and have sold 434,460 shares valued at $39,131,400. Company insiders own 2.80% of the company’s stock.
Dr. Martens Company Profile
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.
Read More
- Five stocks we like better than Dr. Martens
- What is the Shanghai Stock Exchange Composite Index?
- Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
- 10 Best Airline Stocks to Buy
- Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.
